Login
← Go Back
Concord Biotech
CONCORDBIO · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 18, 2023
Stock Price vs Company Growth
1d
1.0%
1w
0.3%
1m
2.8%
3m
14.6%
6m
26.0%
1y
35.2%
all
20.0%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,416 1.0%
1,382
1,702
Company Overview
Sales
1,125 Cr
Growth: 11.7%
Profit after Tax
324 Cr
Growth: -9.0%
Mid Cap
14,819 Cr
P/E: 45.8x
Industry P/E: 33.3x
Fundamentals
Sales (Cr) ₹ 1,125
Growth 11.7%
EBITDA 39.0%
P/S 13.2x
Dividend 0.6%
P/E 45.8x
Book Value ₹ 184
PEG Ratio 3.9x
ROE 17.6%
P/B 7.7x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
Belongs to (18 Indices) view more
Followers (1)
varsha96